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Abstract We studied the transcriptional regulation of human
GM3 synthase (hST3Gal V) during monocytic di¡erentiation of
HL-60 cells induced by 12-O-tetradecanoylphorbol-13-acetate
(TPA). Northern blot and reverse transcription polymerase
chain reaction indicated that the induction of hST3Gal V by
TPA is regulated at the transcriptional level. To elucidate the
mechanism underlying the regulation of hST3Gal V gene ex-
pression during the di¡erentiation of HL-60 cells induced by
TPA, we characterized the promoter region of the hST3Gal V
gene. Functional analysis of the 5P-£anking region of the
hST3Gal V gene by the transient expression method showed
that the 3177 to 383 region, which contains a cAMP respon-
sive element binding protein (CREB) binding site at 3143, func-
tions as the TPA-inducible promoter in HL-60 cells. In addition,
gel shift assays and site-directed mutagenesis indicated that the
CREB binding site at 3143 is crucial for the TPA-induced
expression of the hST3Gal V in HL-60 cells.
: 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Gangliosides, the sialic acid (NeuAc)-containing glyco-
sphingolipids, are found on the outer lea£et of the plasma
membrane of vertebrate cells and are particularly abundant
in the central nervous system [1]. They play important roles in
a large variety of biological processes, such as cell^cell inter-
action, adhesion, cell di¡erentiation, growth control and re-
ceptor function [2]. GM3 is the ¢rst and the simplest of the
gangliosides and is known to play important roles in the
modulation of cell growth through modi¢ed signal transduc-
tion and cell di¡erentiation. GM3 inhibits tyrosine phosphor-
ylation of the epidermal growth factor (EGF) receptor and
EGF-dependent cell growth, independent of receptor^receptor
interaction, whereas De-N-acetyl-GM3 enhances serine phos-
phorylation of the EGF receptor and stimulates cell prolifer-
ation [3]. GM3 induces monocytic di¡erentiation of the hu-
man myeloid and monocytic leukemic cell lines HL-60 and
U937 [4]. GM3 is synthesized by CMP-NeuAc:lactosylcer-
amide K2,3-sialyltransferase (GM3 synthase, EC 2.4.99.9)
which catalyzes the transfer of NeuAc from CMP-NeuAc to
the non-reducing terminal galactose of lactosylceramide. GM3
synthase is a key regulatory enzyme for ganglioside biosyn-
thesis [5] because it catalyzes the ¢rst committed step in the
synthesis of nearly all gangliosides.
HL-60 cells are a promyelocytic cell line that upon 12-O-
tetradecanoylphorbol-13-acetate (TPA) treatment can di¡er-
entiate into monocyte/macrophages [6,7] ; hence they have
been used extensively as a model system to examine the fac-
tors involved in monocyte di¡erentiation. The amount of
GM3 increases markedly with a concomitant increase of hu-
man GM3 synthase (hST3Gal V) activity during monocytic
di¡erentiation of HL-60 cells treated with TPA, which is a
monocyte/macrophage di¡erentiation inducer, but not with a
granulocyte di¡erentiation inducer retinoic acid [8^11]. Also,
hST3Gal V activity is markedly elevated in a time-dependent
manner during monocytic di¡erentiation [9,10]. In addition,
the increases of GM3 and hST3Gal V activity were not re-
lated to the di¡erentiated lineage but to the speci¢c action of
TPA, i.e. activation of protein kinase C (PKC) [9]. These
results suggested that PKC might speci¢cally activate
hST3Gal V, resulting in an increase in the content of GM3
during the di¡erentiation of HL-60 cells induced by TPA, and
that PKC activated by TPA might regulate the expression of
the hST3Gal V gene at the transcriptional level. Therefore, the
regulation of hST3Gal V may be important for the expression
of GM3 in HL-60 cells.
Very recently, we isolated and functionally characterized
the hST3Gal V gene promoter in human hepatoma HepG2
and neuroblastoma SK-N-MC cells [12]. To elucidate the mo-
lecular basis of hST3Gal V gene expression during the di¡er-
entiation of HL-60 cells induced by TPA, in this study we
functionally characterized the ability of the promoter region
to direct up-regulation of reporter gene transcription in re-
sponse to induced HL-60 cell di¡erentiation. The present re-
sults clearly indicate that the cAMP responsive element bind-
ing protein (CREB) binding site of the hST3Gal V promoter
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plays a critical role in transcriptional regulation of the
hST3Gal V gene during HL-60 cell di¡erentiation.
2. Materials and methods
2.1. Materials and cell culture
TPA was purchased from Sigma Chemicals (St. Louis, MO, USA).
The HL-60 cell line was maintained in RPMI 1640 medium (Gibco
BRL, Life Technologies) supplemented with 10% heat-inactivated fe-
tal bovine serum, 100 U/ml penicillin, and 100 Wg/ml streptomycin
under 5% CO2 at 37‡C. To induce di¡erentiation, HL-60 cells were
cultured for di¡erent times in the presence of 30 nM TPA. Cell di¡er-
entiation was monitored by adhesion to culture plates and cell mor-
phology.
2.2. Reverse transcription-polymerase chain reaction (RT-PCR) and
Northern blot analysis
Total RNA was isolated from untreated and TPA-induced HL-60
cells using the Trizol reagent (Invitrogen, Life Technologies). RNA (2
Wg) was subjected to reverse transcription with the random nonamers
and Takara RNA PCR kit (Takara Shuzo, Shiba, Japan) according to
the manufacturer’s protocol. The cDNA was ampli¢ed by PCR with
the following primers: hST3Gal V (1002 bp), 5P-TATACTACTGAA-
GAATGTGACATG-3P (sense) and 5P-TGTTCAAAATTCACGAT-
CAATGCC-3P (antisense); L-actin (247 bp), 5P-CAAGAGATGGC-
CACGGCTGCT-3P (sense) and 5P-TCCTTCTGCATCCTGTCGG-
CA-3P (antisense). The PCR products were separated by gel electro-
phoresis on 3% agarose containing ethidium bromide with 1UTAE
bu¡er. After electrophoresis, the intensity of the bands obtained from
RT-PCR result was estimated using TotalLab software of the Frog
Gel Image Analysis System (CorebioSystem, Seoul, Korea). To assess
the speci¢city of the ampli¢cation, the PCR product (1002 bp) for
hST3Gal V was subcloned into pGEM-T vector (Promega, Madison,
WI, USA) and sequenced and was found to be identical to the ex-
pected cDNA.
Northern blot analysis was performed by the same method as de-
scribed previously [13], using the [K-32P]dCTP-labeled hST3Gal V
fragment (1002 bp obtained by RT-PCR) as a probe.
2.3. Preparation of reporter plasmids and mutagenesis
Reporter plasmids, pGL3-1600 and its derivatives (pGL3-83 to
pGL3-1210) were prepared by insertion of the SacI/BglII fragments
of the plasmids constructed previously [12] into the corresponding
sites of the promoterless and enhancerless luciferase vector pGL3-
Basic (Promega). Mutation with base substitution at the CREB bind-
ing site was constructed using a QuikChange0 II XL site-directed
mutagenesis kit (Stratagene, La Jolla, CA, USA) according to the
manufacturer’s protocol using the following oligonucleotide primers:
CREB-L, 5P-GTCCTCGTGTTGTCAGACCCCGCCCACGCGCC-
CCT-3P and CREB-R, 5P-CGGGGTCTGACAACACGAGGACGC-
GGACGGCCAAT-3P (mutated nucleotides underlined). The presence
of mutation was veri¢ed by sequence analysis.
2.4. Transfection and luciferase assay
For the reporter analysis of the hST3Gal V promoter, transient
transfection of HL-60 cells was carried out by electroporation. Brie£y,
the cultured cells were washed with phosphate-bu¡ered saline and
were then centrifuged at 800 rpm for 5 min at room temperature.
The cells were washed in Puck’s saline bu¡er containing 137 mM
NaCl, 5.4 mM MgCl2, 4.2 mM NaHCO3 and 5.5 mM glucose before
being suspended in permeabilization bu¡er (20 mM HEPES pH 7.0,
137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 6 mM dextrose, pH
7.0) containing 10 Wg of the luciferase reporter constructs and 10 Wg of
a cytomegalovirus-L-galactosidase vector (pCMVL) as a transfection
e⁄ciency control. The 0.9 ml sample (2.5U106 cells) suspended in
permeabilization bu¡er was placed in a cuvette. Electroporation was
accomplished using a Bio-Rad Gene Pulser II at 500 WF and 300 V.
To stimulate resealing of the cell after electroporation, the cells were
incubated for 1 h at 37‡C in 5% CO2 in air and the cells were then
resuspended in RPMI 1640 medium containing 10% fetal bovine se-
rum and cultured for 12 h. TPA (30 nM) was added to induce cell
di¡erentiation at 12 h after transfection and cells were cultured for
another 24 h. Cells were harvested and luciferase activity was mea-
sured using the dual luciferase reporter assay system kit (Promega)
and Luminoskan Ascent (Thermo Labsystems, Helsinki, Finland).
Luciferase activity was normalized to L-galactosidase activity.
2.5. Electrophoretic mobility shift assays (EMSA)
Nuclear extracts from resting and TPA-induced HL-60 cells were
prepared as described previously [13]. EMSAs were performed using a
gel shift assay system kit (Promega) according to the manufacturer’s
instructions. Brie£y, double-stranded oligonucleotides containing the
consensus sequence for CREB (5P-TCCTCGTGACGTCAGACCCC-
3P) were end-labeled with [Q-32P]ATP using T4 polynucleotide kinase
and used as probes for EMSA. Competition was performed using the
unlabeled wild-type CREB or a mutant oligomer 5P-TCCTCG-
TGTTGTCAGACCCC-3P (mut CREB) in 50-fold molar excess. Nu-
clear extract proteins (2 Wg) were preincubated with the gel shift bind-
ing bu¡er (4% glycerol, 1 mM MgCl2, 0.5 mM EDTA, 0.5 mM
dithiothreitol, 50 mM NaCl, 10 mM Tris^HCl (pH 7.5), and 0.05
mg/ml poly(dI-dC)) for 10 min and then incubated with the labeled
probe for 20 min at room temperature. For antibody supershift as-
says, the reactions were performed by preincubating nuclear extracts
with anti-CREB antibody (Upstate Biotechnology, Lake Placid, NY,
USA) at 4‡C for 60 min. Each sample was electrophoresed in a 4%
non-denaturing polyacrylamide gel in 0.5UTBE bu¡er at 250 V for 20
min. The gel was dried and subjected to autoradiography.
Fig. 1. Expression of hST3Gal V mRNA from HL-60 cells before
and after TPA treatment. Total RNA from HL-60 cells was isolated
after 0, 6, 12, 24 or 48 h of TPA treatment and hST3Gal V mRNA
was detected by Northern blot analysis (A) and RT-PCR (B). The
bar graphs represent the intensity of the bands obtained from RT-
PCR by densitometry. The values are meanTS.D. of three indepen-
dent experiments.
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3. Results
3.1. Induction of hST3Gal V expression during HL-60 cell
di¡erentiation
To determine whether hST3Gal V gene expression is regu-
lated during HL-60 cell di¡erentiation, we analyzed the ex-
pression pro¢le of hST3Gal V in HL-60 cells which were
treated with 30 nM TPA for cellular di¡erentiation. As shown
in Fig. 1, Northern blots and RT-PCR showed that the in-
duction of hST3Gal V mRNA became detectable 12 h after
TPA treatment and increased up to 48 h. Morphological
changes and surface attachment of HL-60 cells on the culture
dish were also seen 12 h after TPA treatment and increased up
to 48 h (data not shown). These results clearly show that the
expression of hST3Gal V is stimulated during TPA-induced
monocyte di¡erentiation.
3.2. Determination of hST3Gal V promoter activity during
TPA-induced cell di¡erentiation
To characterize the region regulating the transcription ac-
tivity of hST3Gal V during TPA-induced di¡erentiation of
HL-60 cells, we prepared luciferase constructs carrying 5P-de-
leted hST3Gal V promoters and transfected them into TPA-
untreated HL-60 cells. Regulation of hST3Gal V promoter
activity by TPA was examined. In TPA-uninduced cells, as
shown in Fig. 2, deletion of nucleotides 31600 to 383 had
no signi¢cant e¡ect on transcriptional activity. In TPA-in-
duced cells, however, transcriptional activities were signi¢-
cantly higher than in untreated control cells and gradual de-
letion of 5P sequences from nucleotides 31600 to 3177
resulted in an about four-fold increase in transcriptional ac-
tivity compared with the promoterless and enhancerless con-
trol vector pGL3-Basic. The maximum activity was obtained
Fig. 2. Deletion analysis of hST3Gal V promoter in HL-60 cells before and after TPA treatment. A schematic representation of DNA construc-
tions containing various lengths of the 5P-£anking region of hST3Gal V linked to the luciferase reporter gene is presented. The restriction sites
are shown and the transcription start site is indicated as +1. pGL3-Basic without any promoter and enhancer was used as negative control.
PGL3-Control with SV40 promoter and enhancer was used as positive control. Each construct was co-transfected into HL-60 cells with pCMVL
as the internal control. The transfected cells were incubated in the presence (solid bars) and absence (open bars) of 30 nM TPA for 24 h. Rela-
tive luciferase activity was normalized with L-galactosidase activity derived from pCMVL. The values represent the meanTS.D. for three inde-
pendent experiments with triplicate measurements.
Fig. 3. EMSA with nuclear extracts and the CREB binding site sequence of the hST3Gal V promoter. Nuclear extracts isolated from HL-60
cells after 0, 6, 12, 24 or 48 h of TPA treatment were incubated with 32P-labeled wild-type probe or unlabeled wild-type probe, or labeled mu-
tant CREB probe. For competition experiments, a 50-fold molar excess of unlabeled wild-type CREB oligonucleotides was used. The DNA^
protein complexes were analyzed on a 4% non-denaturing polyacrylamide gel.
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with pGL3-177 and reached about eight-fold higher activity
than pGL3-Basic. Further deletion to nucleotide 383 mark-
edly reduced transcriptional activity to a level similar to that
of the control vector pGL3-Basic. These results show that the
region from nucleotides 3177 to 383 functions as the TPA-
inducible promoter in HL-60 cells.
3.3. Identi¢cation of TPA-responsive element in nucleotides
3177 to 383 region of the hST3al V promoter
Our previous study [12] showed that this region from 3177
to 383 is GC-rich (GC content 74%) and contains NFY,
CREB, SP1, EGR3 and MZF1 binding sites. These binding
sites are present in the inverted orientation except for CREB
and MZF1. Moreover, the TransSignal Protein/DNA array
with nuclear extract of HeLa cells suggested that of these sites
only the consensus CREB binding site (TGACGTCA) at po-
sition 3143 to 3136 might be contributory to the hST3Gal V
promoter activity [14].
To determine whether this site contributes to TPA-induced
expression of hST3Gal V in HL-60 cell, we performed gel
EMSA using a double-stranded 32P-labeled oligo fragment
(20 bp) containing the consensus sequence for CREB, and
nuclear extract from TPA-treated HL-60 cells. As shown in
Fig. 3, a single complex that binds to this fragment was de-
tected, and the intensity of this complex increased signi¢cantly
12 h after TPA treatment and remained at a steady level for
the next 48 h. This binding could be competed with a 50-fold
molar excess of unlabeled oligo fragment itself, or mutant
CREB oligo fragment. To clarify whether this band of
DNA^protein complex contained CREB, we performed gel
mobility shift analysis in the presence of anti-CREB antibody
(Fig. 4). The incubation of nuclear extracts with anti-CREB
antibody resulted in a supershift of the complex with a con-
comitant diminution of the retarded band (Fig. 4, lanes 3 and
5). These results indicated that the binding to 20 bp fragment
is CREB-speci¢c, and a complex contains CREB protein.
To further con¢rm that this CREB binding site plays an
important role in TPA-induced expression of hST3Gal V in
HL-60 cells, a CREB mutant (pGL3-177mtCREB) was gen-
erated which contains the exact same construct as wild-
type pGL3-177 except that two nucleotides within the CREB
binding site had been changed (from TGACGTCA to
TGTTGTCA). It was clearly observed that this change abol-
ished CREB binding to this CREB binding site, since the
mutant CREB oligomer (containing TGTTGTCA) could
not compete for the binding while the wild-type CREB olig-
omer (containing TGACGTCA) could (Fig. 3). In TPA-
treated HL-60 cells, as expected, this mutation markedly re-
duced transcriptional activity to a level comparable to that
exhibited by the promoterless and enhancerless control vector
pGL3-Basic (Fig. 5). These combined results indicate that this
CREB site is crucial for the TPA-induced expression of
hST3Gal V, and that the CREB binding to this site is in-
volved in the induction of hST3Gal V by TPA.
4. Discussion
Previous studies have shown that hST3Gal V activity and
the amount of GM3 ganglioside markedly increase hST3Gal
V in HL-60 cells treated with TPA, which is a well-known
monocyte/macrophage di¡erentiation inducer [8^11]. Those
results have also suggested that the dramatic GM3 increase
Fig. 4. Gel supershift analysis with nuclear extracts and anti-CREB
antibody. Supershift analysis was performed in the presence of anti-
CREB antibody (2 Wg). The arrowhead indicates the shift of the
complex by anti-CREB antibody.
Fig. 5. E¡ect of mutation in the CREB binding site on hST3Gal V promoter activity. pGL3-Basic without any promoter and enhancer was
used as negative control. PGL3-Control with SV40 promoter and enhancer was used as positive control. Each construct was co-transfected into
HL-60 cells with pCMVL as the internal control. The transfected cells were incubated in the presence (solid bars) and absence (open bars) of
30 nM TPA for 24 h. Relative luciferase activity was normalized with L-galactosidase activity derived from pCMVL. The values represent the
meanTS.D. for three independent experiments with triplicate measurements.
FEBS 27833 19-11-03
H.-J. Choi et al./FEBS Letters 555 (2003) 204^208 207
is the consequence of the up-regulation of hST3Gal V. How-
ever, transcriptional regulation of hST3Gal V during TPA-
induced monocyte di¡erentiation of HL-60 cells has not
been examined at the molecular levels. Here, we report that
the expression of hST3Gal V is up-regulated during TPA-in-
duced monocyte di¡erentiation of HL-60 cells. TPA treatment
increased hST3Gal V mRNA levels in a time-dependent fash-
ion: the induction of hST3Gal V mRNA became detectable
12 h after TPA treatment and increased up to 48 h. The
hST3Gal V activity also increased in a time-dependent man-
ner upon TPA treatment (data not shown). The marked in-
creases of hST3Gal V activity and GM3 levels in HL-60 cells
have been also observed 12 h after TPA treatment and in-
creased up to 48 h [9,10]. Therefore, these results clearly in-
dicate that the relative levels of hST3Gal V mRNA and its
protein are increased in a time-dependent fashion by TPA
treatment in HL-60 cells.
Our results in this study show that the region between 3177
and 383 in the hST3Gal V promoter functions as the core
promoter essential for transcriptional activation of hST3Gal
V in TPA-induced HL-60 cells. This region was found to be
also needed for the enhancer activity of the hST3Gal V pro-
moter in SK-N-MC and HepG2 cells [12]. Endogenous
hST3Gal V gene expression was detected in both cells by
RT-PCR [12], but not in TPA-uninduced HL-60 cells. This
indicates that this region functions as the TPA-inducible pro-
moter in HL-60 cells. Our previous study revealed the exis-
tence of several transcription factor binding sites such as
NFY, CREB, SP1, EGR3 and MZF1 in this region [12]. A
recent report has suggested that only the consensus CREB
binding site (TGACGTCA) at position 3143 to 3136 in
this region might contribute to hST3Gal V promoter activity
[14]. Our present result by site-directed mutagenesis indicates
that this CREB element mediates TPA-dependent up-regula-
tion of hST3Gal V expression. By EMSA, we demonstrate
that CREB binds to this site of the hST3Gal V promoter in
a time-dependent manner by TPA induction, as shown by the
increases of hST3Gal V expression, enzyme activity and GM3
levels. Thus, our data strongly suggest that CREB may play
an import role during TPA-induced monocyte di¡erentiation
of HL-60 cells.
CREB is a transcription factor that is the target of a variety
of signaling pathways mediating cell responses to extracellular
stimuli, involving proliferation, di¡erentiation, and adaptive
responses of cell processes [15,16]. Several signal pathways,
such as protein kinase A, PKC, Ca2þ/calmodulin kinases,
stress-activated protein kinase/c-Jun N-terminal kinase, P38,
and extracellular signal-regulated kinase mitogen-activated
protein kinases (MAPKs), could activate CREB binding to
CRE, and the capacity of CREB to activate transcription is
regulated by phosphorylation at serine 133 [15,16]. A previous
study has shown that the activation of PKC by TPA in hu-
man ¢broblasts stimulates CREB phosphorylation and subse-
quent CREB-mediated gene transcription [17]. Other studies
have also indicated that CREB phosphorylation in oligoden-
drocytes may be mediated by PKC and MAPK-dependent
signal transduction pathways [18^20].
It has been suggested that PKC may speci¢cally activate
hST3Gal V, resulting in an increase in the content of GM3
ganglioside during the di¡erentiation of HL-60 cells induced
by TPA, and that PKC activated by TPA may regulate the
expression of the hST3Gal V gene at the transcriptional level
[9]. It is possible, therefore, that the expression of the
hST3Gal V gene may be activated by PKC and MAPK-de-
pendent signaling pathway. Further studies are scheduled to
dissect these pathways for clarifying the up-regulation-associ-
ated mechanisms of hST3Gal V expression in TPA-induced
HL-60 cells.
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